Rebeca Higuera

Characteristics and Progression of Preclinical Inflammatory Bowel Disease

Iago Rodríguez–Lago, Olga Merino, Irene Azagra et al. · Clinical Gastroenterology and Hepatology · 2017 · 39 citations

Inflammation, Autoimmune Disease, Immunology +4

Adalimumab treatment of anti-TNF-naïve patients with ulcerative colitis: Deep remission and response factors

Carmen Muñoz‐Villafranca, Jone Ortiz de Zárate, Paz Arreba et al. · Digestive and Liver Disease · 2018 · 23 citations

Inflammation, Rheumatology, Deep Remission +10

Early dose optimization of golimumab induces late response and long-term clinical benefit in moderately to severely active ulcerative colitis

Carlos Taxonera, Marisa Iborra, Marta Maia Boscá-Watts et al. · Current Medical Research and Opinion · 2019 · 18 citations

Early microscopic findings in preclinical inflammatory bowel disease

Iago Rodríguez–Lago, C Castellanos Ramirez, Olga Merino et al. · Digestive and Liver Disease · 2020 · 18 citations

Inflammation, Autoimmune Disease, Early Microscopic Findings +6

Granulocyte‐Monocyte Apheresis as an Adjuvant Therapy to Anti‐Tumor Necrosis Factor Drugs for Ulcerative Colitis

Iago Rodríguez–Lago, Laura Irwin, Encarnación Fernández et al. · Therapeutic Apheresis and Dialysis · 2017 · 14 citations